Nesrine Lajmi

576 total citations
14 papers, 472 citations indexed

About

Nesrine Lajmi is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Nesrine Lajmi has authored 14 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Hematology and 4 papers in Oncology. Recurrent topics in Nesrine Lajmi's work include Immunotherapy and Immune Responses (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Cell Function and Interaction (4 papers). Nesrine Lajmi is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Multiple Myeloma Research and Treatments (6 papers) and Immune Cell Function and Interaction (4 papers). Nesrine Lajmi collaborates with scholars based in Germany, United States and Switzerland. Nesrine Lajmi's co-authors include York Hildebrandt, Katrin Bartels, Carsten Bokemeyer, Djordje Atanackovic, Sabrina Meyer, Tim Luetkens, Sebastian Kobold, Nicolaus Kröger, Yanran Cao and Henrike Reinhard and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and British Journal of Haematology.

In The Last Decade

Nesrine Lajmi

14 papers receiving 464 citations

Peers

Countries citing papers authored by Nesrine Lajmi

Since Specialization

Citations

This map shows the geographic impact of Nesrine Lajmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nesrine Lajmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nesrine Lajmi more than expected).

Fields of papers citing papers by Nesrine Lajmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nesrine Lajmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nesrine Lajmi. The network helps show where Nesrine Lajmi may publish in the future.

Co-authorship network of co-authors of Nesrine Lajmi

This figure shows the co-authorship network connecting the top 25 collaborators of Nesrine Lajmi. A scholar is included among the top collaborators of Nesrine Lajmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nesrine Lajmi. Nesrine Lajmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm 2024 ·SHILAP Revista de lepidopterología ·Nesrine Lajmi, (unknown), Apostolos Tsiachristas, (unknown), Kerrie Woods, Charles Crichton, (unknown), Hizni Salih, (unknown), (unknown), (unknown), (unknown), Kevin M. Bradley, (unknown), Daniel R. McGowan, Jim Davies, Matthew Prime, (unknown)	5
2	Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma 2015 ·Journal of Translational Medicine ·Sara Yousef, (unknown), Nesrine Lajmi, Katrin Bartels, Nicolaus Kröger, Tim Luetkens, Djordje Atanackovic	4
3	Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma 2015 ·British Journal of Haematology ·Nesrine Lajmi, Tim Luetkens, Sara Yousef, (unknown), Yanran Cao, York Hildebrandt, Katrin Bartels, Nicolaus Kröger, Djordje Atanackovic	9
4	The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting 2013 ·Human Vaccines & Immunotherapeutics ·Djordje Atanackovic, Henrike Reinhard, Sabrina Meyer, (unknown), Tobias Grob, Tim Luetkens, Sara Yousef, Yanran Cao, York Hildebrandt, (unknown), Katrin Bartels, Nesrine Lajmi, Heribert Stoiber, Nicolaus Kröger, Judith Atz, Diane Seimetz, Jakob R. Izbicki, Carsten Bokemeyer	22
5	Role of Interleukin 16 in Multiple Myeloma 2012 ·JNCI Journal of the National Cancer Institute ·(unknown), York Hildebrandt, (unknown), Yan Cao, C. Keller, Jens Panse, Sabrina Meyer, Henrike Reinhard, Katrin Bartels, Nesrine Lajmi, Orhan Sezer, A. R. Zander, Andreas H. Marx, Ria Uhlig, Jozef Zustin, Carsten Bokemeyer, Nicolaus Kröger	38
6	Longitudinal Analysis of Tetanus- and Influenza-Specific IgG Antibodies in Myeloma Patients 2012 ·SHILAP Revista de lepidopterología ·Sebastian Kobold, Tim Luetkens, (unknown), Yanran Cao, York Hildebrandt, Orhan Sezer, Henrike Reinhard, (unknown), Katrin Bartels, Nesrine Lajmi, Friedrich Haag, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic	8
7	Cancer‐testis antigen expression and its epigenetic modulation in acute myeloid leukemia 2011 ·American Journal of Hematology ·Djordje Atanackovic, Tim Luetkens, (unknown), (unknown), Yanran Cao, York Hildebrandt, Sabrina Meyer, Katrin Bartels, Henrike Reinhard, Nesrine Lajmi, Susanna Hegewisch‐Becker, Georgia Schilling, Uwe Platzbecker, Guido Kobbe, Thomas Schroeder, Carsten Bokemeyer, Nicolaus Kröger	88
8	Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation 2011 ·SHILAP Revista de lepidopterología ·Sebastian Kobold, (unknown), Tim Luetkens, Yanran Cao, Orhan Sezer, (unknown), Henrike Reinhard, (unknown), Katrin Bartels, York Hildebrandt, Nesrine Lajmi, Andreas H. Marx, Friedrich Haag, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic	8
9	Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma 2011 ·Haematologica ·Djordje Atanackovic, Jens Panse, York Hildebrandt, (unknown), Sebastian Kobold, Yan Cao, (unknown), Sabrina Meyer, Henrike Reinhard, Katrin Bartels, Nesrine Lajmi, A R Zander, Andreas H. Marx, Carsten Bokemeyer, Nicolaus Kröger	55
10	NY-ESO-1 expression and immunogenicity in prostate cancer patients. 2011 ·PubMed ·Asma Gati, Nesrine Lajmi, (unknown), Raja Marrakchi, Mohamed Chébil, Amel Benammar-Elgaaïed	15
11	The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients 2010 ·Experimental Hematology ·Yanran Cao, Tim Luetkens, Sebastian Kobold, York Hildebrandt, (unknown), Nesrine Lajmi, Sabrina Meyer, Katrin Bartels, Axel R. Zander, Carsten Bokemeyer, Nicolaus Kröger, Djordje Atanackovic	73
12	An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body 2010 ·Journal of Immunological Methods ·Yanran Cao, (unknown), Sebastian Kobold, Nesrine Lajmi, Sabrina Meyer, Katrin Bartels, York Hildebrandt, Tim Luetkens, (unknown), Nicolaus Kröger, Carsten Bokemeyer, Djordje Atanackovic	38
13	Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia 2010 ·Leukemia Research ·Tim Luetkens, (unknown), (unknown), (unknown), Ruken Ö. Akbulak, (unknown), York Hildebrandt, (unknown), Sebastian Kobold, Sabrina Meyer, (unknown), Katrin Bartels, Nesrine Lajmi, Yanran Cao, Nicolaus Kröger, Carsten Bokemeyer, Tim H. Brümmendorf, Djordje Atanackovic	30
14	Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells 2009 ·Haematologica ·Djordje Atanackovic, York Hildebrandt, (unknown), Yan Cao, Tim Luetkens, Sabrina Meyer, Sebastian Kobold, Katrin Bartels, Caroline Pabst, Nesrine Lajmi, (unknown), Tanja Stahl, A. R. Zander, Carsten Bokemeyer, Nicolaus Kröger	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact